Context: Atherothrombotic cardiovascular disease has both functional and anatomic components that can be assessed non invasively.
Results: History of hypertension, diabetes, dyslipidemia, cardiovascular heredity, smoking and body mass index were similar in both groups. All blood pressure parameters (clinic and 24-hour ambulatory blood pressure monitoring) were higher in group 2 (p<0.01). Metabolic abnormalities were more often experienced after an acute coronary syndrome, with higher prevalence in metabolic syndrome (28% vs. 10%, p=0.02) and higher triglycerides (1.76±0.91 vs. 1.36±0.68 mmol/l, p=0.02) and glucose levels (5.89±2.16 vs. 4.92±0.74 mmol/l, p=0.003). Carotid intima-media thickness and carotid-tofemoral pulse wave velocity were significantly higher in group 2 than group 1 (769±180 vs. 701±136 μm, p=0.03; 12.5±3.5 vs.10.7±2.4 m/s, p=0.006). Prevalence of endothelial dysfunction and carotid plaques were similar in acute coronary syndrome and ischemic atherothrombotic stroke group (86% vs. 74%, p=NS and 80% vs. 78%, p=NS, respectively).
Conclusion:
In stroke patients, aortic stiffness and carotid wall thickness were higher than in acute coronary syndrome patients. These structural and functional differences may have a direct involvement in the occurrence of the event.
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Lower limb ischemia following the use of vascular closure devices: percutaneous management Sofiene Rekik [Orateur] (1), Jerome Brunet (2), Gilles Bayet (2), Francois Xavier Hager (2), Laurent Meille (2), Jean Michel Quatre (2), Joel Sainsous (2) (1) CH Avignon, Avignon, France -(2) Clinique Rhône-Durance, Cardiologie, Avignon, France Aim: To assess immediate and midterm outcomes of a systematic endovascular approach for the treatment of lower limb ischemia following the use of vascular closure devices (VCD) after percutaneous coronary and peripheral interventional procedures.
Methods: From January 2006 to December 2008, all the patients who developed lower limb ischemia following the use of a VCD in a single high volume French institution were systematically managed percutaneously and constituted the population of this study. Clinical characteristics, immediate and midterm outcomes are reported.
Results: 18 patients (3 males and 15 females) were included. Mean age was 67.1 years. Closure devices were Angio-seal* in 12 cases, Starclose* in 3 cases and Perclose* in 3 cases. On average, lower limb ischemia occurred 6.5 days (range 1-28 days) after device placement. Culprit lesion was located in the left common femoral artery in 6 cases and in the right common femoral artery in 12 cases. Secondary vascular access was obtained through the humeral artery in 12 cases and the controlateral femoral artery in 6 cases. A 90 cm-long 6F Destination* guiding sheath was used in 13 cases and a 6F multipurpose guiding catheter in the remainder. The occlusion site was successfully crossed in all cases using 0.014 inch coronary guidewires in 8 cases and a hydrophilic 0.035 inch Terumo glidewire in 8 cases. 12 patients were treated with balloon angioplasty and 6 with stent implantation. Angiographic success was obtained in all the cases. After a mean 27.3 months follow-up, only two patients initially treated by PTA needed re-intervention (due to symptomatic restenosis ) consisting in a balloon angioplasty in one case and stent implantation in the second case (after respectively 3 and 4 months). At final follow-up, all the patients were asymptomatic Aim: the aim of this study is to evaluate the impact of body mass index (BMI) on HRV and HRT in hypertensive patients.
Methods: 85 patients with hypertension (mean age 57±11 years) underwent 24 hour Holter recording. The following HRV parameters were studied: (SDNN, SDNN5, RMSSD, BF, HF and BF/HF). HRT parameters were also analysed (TO and TS). Patients were divided in three groups according to their BMI:. group 1: BMI<25 kg/cm², group 2: BMI between 25 and 30 kg/cm² and group 3: BMI>30 kg/cm². Resultats: HRV and HRT parameters were comparable in the three groups 
